In addition, although CIP was shown to stimulate TRAIL treatment in the lung cancer cell line A549, the molecular basis by which CIP sensitizes TRAIL-mediated apoptosis was not fully investigated yet. This evidence concerns the gene TNFSF10 and lung carcinoma.